Literature DB >> 8355032

Modulation of multidrug resistance: at the threshold.

B I Sikic.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8355032     DOI： 10.1200/JCO.1993.11.9.1629

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  20 in total

1.  Dexverapamil to modulate vinblastine resistance in metastatic renal cell carcinoma.

Authors:  G H Mickisch; M A Noordzij; A vd Gaast; P Gebreamlack; K U Köhrmann; E Mogler-Drautz; H Kupper; F H Schröder
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

2.  Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.

Authors:  A H Schinkel; U Mayer; E Wagenaar; C A Mol; L van Deemter; J J Smit; M A van der Valk; A C Voordouw; H Spits; O van Tellingen; J M Zijlmans; W E Fibbe; P Borst
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 3.  The challenge of drug resistance in cancer treatment: a current overview.

Authors:  Michail Nikolaou; Athanasia Pavlopoulou; Alexandros G Georgakilas; Efthymios Kyrodimos
Journal:  Clin Exp Metastasis       Date:  2018-05-24       Impact factor: 5.150

Review 4.  The biology of the P-glycoproteins.

Authors:  C R Leveille-Webster; I M Arias
Journal:  J Membr Biol       Date:  1995-01       Impact factor: 1.843

Review 5.  Classical multidrug resistance in acute myeloid leukaemia.

Authors:  E Paietta
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

6.  MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors.

Authors:  K Tóth; M M Vaughan; N S Peress; H K Slocum; Y M Rustum
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

7.  Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.

Authors:  M Müller; C Meijer; G J Zaman; P Borst; R J Scheper; N H Mulder; E G de Vries; P L Jansen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

Authors:  A H Schinkel; E Wagenaar; C A Mol; L van Deemter
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

Review 9.  Molecular biology of leukemia for the clinician.

Authors:  E Paietta
Journal:  Med Oncol       Date:  1995-09       Impact factor: 3.064

10.  Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.

Authors:  U Mayer; E Wagenaar; B Dorobek; J H Beijnen; P Borst; A H Schinkel
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.